The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Kaltsas, G, Papadogias, D, Grossman, AB
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2004

Míreanna comhchosúla

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
de réir: Chrisoulidou, A, et al.
Foilsithe / Cruthaithe: (2007)

The clinical genetics of phaeochromocytoma and paraganglioma
de réir: P. T. Kavinga Gunawardane, et al.

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
de réir: Bomanji, J, et al.
Foilsithe / Cruthaithe: (1993)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
de réir: Bouloux, P, et al.
Foilsithe / Cruthaithe: (1986)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
de réir: Mukherjee, J, et al.
Foilsithe / Cruthaithe: (2001)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
de réir: Foo, S.H., et al.
Foilsithe / Cruthaithe: (2010)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
de réir: Srirangalingam, U, et al.
Foilsithe / Cruthaithe: (2008)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
de réir: Kaltsas, G, et al.
Foilsithe / Cruthaithe: (2005)

Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
de réir: U. Srirangalingam, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Using parenclitic networks on phaeochromocytoma and paraganglioma tumours provides novel insights on global DNA methylation
de réir: Dimitria Brempou, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Personalized diagnostics of chromaffin tumors (pheochromocytoma, paraganglioma) in oncoendocrinology
de réir: Pavel O. Rumyantsev, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
de réir: Sofia Maria Lider Burciulescu, et al.
Foilsithe / Cruthaithe: (2023-02-01)

A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
de réir: Christopher S. Boot
Foilsithe / Cruthaithe: (2023-09-01)

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
de réir: Srirangalingam, U, et al.
Foilsithe / Cruthaithe: (2009)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
de réir: Kaltsas, G, et al.
Foilsithe / Cruthaithe: (2004)

Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension.
de réir: Frankton, S, et al.
Foilsithe / Cruthaithe: (2009)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
de réir: Astuti, D, et al.
Foilsithe / Cruthaithe: (2003)

Predictors of outcome in phaeochromocytomas and paragangliomas [version 1; referees: 3 approved]
de réir: Marlo Nicolas, et al.
Foilsithe / Cruthaithe: (2017-12-01)

A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
de réir: Prodromos Chatzikyriakou, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
de réir: Druce, MR, et al.
Foilsithe / Cruthaithe: (2009)

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
de réir: Samsudin, Intan Nureslyna, et al.
Foilsithe / Cruthaithe: (2018)

Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
de réir: Andrea Luchetti, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
de réir: Poplawski NK, et al.
Foilsithe / Cruthaithe: (2012-04-01)

The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
de réir: Sheaves, R, et al.
Foilsithe / Cruthaithe: (1995)

Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
de réir: Nölting, S, et al.
Foilsithe / Cruthaithe: (2012)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
de réir: Calum Urquhart, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Unilateral Sporadic Carotid Paraganglioma
de réir: Sushil G. Kachewar, et al.
Foilsithe / Cruthaithe: (2011-12-01)

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
de réir: Dahia, P, et al.
Foilsithe / Cruthaithe: (1997)

Malignant pituitary tumours.
de réir: Kaltsas, G, et al.
Foilsithe / Cruthaithe: (1998)

Rare presentation of collapse and cardiomyopathy in phaeochromocytoma
de réir: Rajiv Singh, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Phaeochromocytoma Crisis: Two Cases of Undiagnosed Phaeochromocytoma Presenting after Elective Nonrelated Surgical Procedures
de réir: P. C. Johnston, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
de réir: Wong Nora, et al.
Foilsithe / Cruthaithe: (2006-01-01)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
de réir: Nastos, K, et al.
Foilsithe / Cruthaithe: (2017)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
de réir: Lawrence, J, et al.
Foilsithe / Cruthaithe: (2004)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
de réir: Kaltsas, G, et al.
Foilsithe / Cruthaithe: (2002)

Intracerebral haemorrhage: A rare presentation of phaeochromocytoma
de réir: Swati Chhikara, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
de réir: Kaltsas, G, et al.
Foilsithe / Cruthaithe: (2003)

A Rare Case: Sporadic Bladder Paraganglioma
de réir: Hakan Ercil, et al.
Foilsithe / Cruthaithe: (2013-08-01)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
de réir: David J. Pinato, et al.
Foilsithe / Cruthaithe: (2017-11-01)

MIBG scans for phaeochromocytoma: time to abandon the technique?
de réir: Grossman, A, et al.
Foilsithe / Cruthaithe: (2009)